Health Care: Drugs

Synthetic Biologics Inc (SYN: AMEX)

$0.6392 n/a | n/a%
06/23/17 - 04:02 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 0.00 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 0.00
Selling, General, and Administrative Expenses 10.14M 8.07M 6.01M 5.83M
Research & Development 29.11M 32.91M 14.49M 6.51M
Operating Income before D & A (EBITDA) -39.25M -40.98M -20.50M -12.34M
Depreciation & Amortization 157.00K 72.00K 20.00K 43.00K
Interest Income 37.00K 6.00K 3.00K 33.00K
Other Income - Net 11.41M -3.81M 715.00K -12.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -27.96M -44.86M -19.80M -12.36M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -27.96M -44.86M -19.80M -12.36M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest -548.00K -1.05M 0.00 -1.00K
Net Income From Continuing Operations -27.80M -44.78M -19.78M -12.32M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -27.80M -44.78M -19.78M -12.32M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -27.25M -43.74M -19.78M -12.32M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-27.80M -44.78M -19.78M -12.32M
Preferred Dividends
Net Income Available To Common -27.80M -44.78M -19.78M -12.32M
Basic EPS from Continuing Ops. -0.29 -0.54 -0.32 -0.27
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.29 -0.54 -0.32 -0.27
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.29 -0.54 -0.32 -0.27
Basic Normalized Net Income/Share -0.29 -0.54 -0.32 -0.27
EPS fr Continuing Ops. -0.29 -0.54 -0.32 -0.27
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.29 -0.54 -0.32 -0.27
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.29 -0.54 -0.32 -0.27
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.29 -0.54 -0.32 -0.27
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SYN

Latest SYN Headlines from TheStreet

More Financial News for SYN

Press Releases for SYN

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter